| Recruiting | Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS NCT07461545 | Northern Jiangsu People's Hospital | N/A |
| Recruiting | Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD NCT07461532 | Northern Jiangsu People's Hospital | N/A |
| Recruiting | Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis NCT07521332 | Asian Institute Of Medical Sciences | Phase 4 |
| Not Yet Recruiting | Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation NCT07422701 | Peking University First Hospital | — |
| Not Yet Recruiting | Endoscopic Ultrasound-guided Measurement of Portal Vein Pressure Gradient NCT07062289 | Zhejiang University | N/A |
| Not Yet Recruiting | Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirr NCT06818279 | Institute of Liver and Biliary Sciences, India | Phase 2 / Phase 3 |
| Not Yet Recruiting | Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT NCT06319131 | Shanghai Zhongshan Hospital | N/A |
| Not Yet Recruiting | Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis NCT06122753 | West China Hospital | N/A |
| Unknown | Portal Vein Thrombosis in Neonate With Umbilical Catheter NCT06150807 | Assiut University | — |
| Unknown | Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children NCT06117488 | Assiut University | — |
| Recruiting | Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC NCT07132515 | Mansoura University | Phase 4 |
| Unknown | H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis NCT05872841 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Inv NCT05625893 | Samsung Medical Center | Phase 2 |
| Recruiting | Freiburg TIPS Registry NCT05782556 | University Hospital Freiburg | — |
| Unknown | IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation NCT05339581 | RenJi Hospital | N/A |
| Completed | HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT NCT05166239 | Peking University | Phase 2 |
| Unknown | Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome NCT05123326 | Post Graduate Institute of Medical Education and Research, Chandigarh | — |
| Completed | Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring NCT06005883 | Keimyung University Dongsan Medical Center | — |
| Withdrawn | Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis NCT04055389 | Jonathan Stine | Phase 1 |
| Completed | Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis NCT05012501 | The Affiliated Hospital of Qingdao University | — |
| Unknown | Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis NCT04433481 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT NCT04387695 | First Affiliated Hospital of Zhejiang University | Phase 3 |
| Completed | Safety of Anticoagulant Therapy After Endoscopic Treatment NCT04976543 | Qilu Hospital of Shandong University | Phase 4 |
| Unknown | Neo-TACE-HAIC for PVTT-HCC NCT04181931 | Sun Yat-sen University | N/A |
| Completed | Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal NCT05360641 | University Hospital, Caen | — |
| Unknown | The Effect of Rifaximin on Portal Vein Thrombosis NCT03631147 | Shanghai Zhongshan Hospital | N/A |
| Completed | EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate NCT03477149 | Assistance Publique - Hôpitaux de Paris | N/A |
| Unknown | Vienna Vascular Liver Disease Study NCT03541057 | Medical University of Vienna | — |
| Unknown | TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis NCT02485184 | Air Force Military Medical University, China | N/A |
| Completed | Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis NCT03009461 | Peking University | Phase 2 |
| Unknown | Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma NCT03902678 | Mansoura University | N/A |
| Completed | Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis NCT04173429 | Qilu Hospital of Shandong University | Phase 4 |
| Unknown | Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS NCT03031717 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | — |
| Recruiting | Indicators Affecting PVT Recanalization NCT07473375 | Shanghai Zhongshan Hospital | — |
| Withdrawn | Chances in Portal System Flow After Two Bariatric Procedures NCT02733770 | Assuta Medical Center | N/A |
| Recruiting | A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation NCT06513780 | Ru-zhou Cai | — |
| Unknown | The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT NCT02630095 | Shanghai Zhongshan Hospital | Phase 4 |
| Unknown | Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study NCT02627053 | Università degli Studi dell'Insubria | Phase 3 |
| Completed | Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism NCT02585713 | Academic and Community Cancer Research United | Phase 3 |
| Unknown | TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV NCT02853526 | Zaibo Jiang | Phase 3 |
| Unknown | The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis NCT02398357 | Shanghai Zhongshan Hospital | Phase 4 |
| Completed | Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis NCT02250391 | Nihon Pharmaceutical Co., Ltd | Phase 3 |
| Completed | Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV NCT03201367 | Zagazig University | N/A |
| Unknown | Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis NCT03193502 | Sherief Abd-Elsalam | Phase 3 |
| Completed | Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis NCT02069457 | Jia Ji-Dong | — |
| Completed | A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients NCT05541562 | The Affiliated Hospital of Qingdao University | — |
| Completed | Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis NCT05132192 | Elvan Onur Kirimker | — |
| Terminated | Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular NCT01690715 | Hospital Sirio-Libanes | — |
| Withdrawn | Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver NCT01631877 | Institute of Liver and Biliary Sciences, India | N/A |
| Completed | Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry NCT01470547 | University of Roma La Sapienza | — |
| Completed | Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patien NCT01326949 | Air Force Military Medical University, China | N/A |
| Completed | Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With C NCT01095185 | Juan A. Arnaiz | Phase 3 |
| Completed | TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis NCT01556282 | Emory University | N/A |
| Terminated | Anticoagulation Post Laparoscopic Splenectomy NCT00769873 | University of Alberta | Phase 2 |
| Completed | Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes NCT07252570 | Centre Hospitalier Universitaire de Nice | — |
| Withdrawn | Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis NCT02526303 | Air Force Military Medical University, China | N/A |